Early modeling put sickle cell gene therapy coverage near 11 cents per member per month.
News|Articles|March 16, 2026
Is Climate Change Quietly Fueling a Global Physical Inactivity Crisis?
Author(s)Maggie L. Shaw
Fact checked by: Rose McNulty
Rising global temperatures are silently driving a sedentary crisis, and the world’s most vulnerable populations are paying the steepest price.
Advertisement
Advertisement
Rising temperatures could be making
Related to this article
Experts at AMCP Nexus say biosimilar launches should prompt payers to revisit step therapy and measure value beyond market share.
Three experts apply policy, pharmacy operations, and member-level lenses to the same prescriptions to show why cost at the counter decides adherence.
Most Medicaid unwinding losses were procedural. mPulse's SriVani Ganti explains how plans can keep eligible members.
Youths with depression had about twice the odds of prescription drug misuse and 4 times the odds of use disorder, compared with peers without depression.
Initial frontal fibrosing alopecia treatment was largely similar in Black and White patients, though tetracycline use was higher in Black patients.
HHS does not intend to take enforcement action against pharmacies compounding BPC-157 and 5 other unapproved peptides if they meet 10 conditions.
Cost and access, not side effects, drive GLP-1 discontinuation, and obesity should be covered like diabetes, says Fatima Cody Stanford, MD.
Advertisement
Advertisement